Financials

  • Market Capitalization 647.72 M
  • Employee 191
  • Founded 2006
  • CEO N/A
  • Website www.cormedix.com
  • Headquarter Delaware, United States
  • FIGI BBG000Q4BQK0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
3.6
Rapporto prezzo/fatturato
0

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2747
PRME
Prime Medicine, Inc. - Common Stock
3.64 USD+1.68%+10.98%+18.57%+5.20%660.21 M USD
2751
MDXG
MiMedx Group, Inc - Common Stock
4.51 USD+2.04%+4.88%+3.44%-37.19%657.38 M USD
2774
SLN
Silence Therapeutics Plc - American Depository Share
13.45 USD-0.59%+2.13%+17.78%+163.73%635.47 M USD
2784
ALT
Altimmune, Inc. - Common Stock
3.24 USD+2.86%+8.72%+8.00%-12.90%630.24 M USD

Notizie